<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>ARC1172 is a 41-mer DNA aptamer selected to bind the A1 domain of <z:e sem="disease" ids="C0042974" disease_type="Disease or Syndrome" abbrv="">von Willebrand</z:e> factor (VWF) </plain></SENT>
<SENT sid="1" pm="."><plain>A derivative of ARC1172 with modifications to increase intravascular survival inhibits carotid artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in a Cynomolgus macaque model and inhibits VWF-dependent platelet aggregation in humans, suggesting that such aptamers may be useful to prevent or treat <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>In the crystal structure of a VWF A1-ARC1172 complex, the aptamer adopts a three-stem structure of mainly B-form DNA with three noncanonical base pairs and 9 unpaired residues, 6 of which are stabilized by base-base or base-deoxyribose stacking interactions </plain></SENT>
<SENT sid="3" pm="."><plain>The aptamer-protein interface is characterized by <z:chebi fb="36" ids="36916">cation</z:chebi>-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">pi</z:e> interactions involving Arg, Lys, and Gln residues, often stabilized by H-bonds with adjacent bases </plain></SENT>
<SENT sid="4" pm="."><plain>The ARC1172 binding site on the A1 domain overlaps with that of botrocetin and clashes with <z:chebi fb="2" ids="17089">glycoprotein</z:chebi> Ibalpha binding at an adjacent site, which accounts for the antithrombotic activity of ARC1172 and related aptamers </plain></SENT>
</text></document>